A Prescription for Health System Strategy Development

The role of health systems in the delivery of care in the US has been on the rise over the past decade. As health systems continue to evolve and consolidate, they can exert significant influence over branded drug utilization, leading to the need for biopharma executives to develop an effective strategy for engaging with health system customers. This white paper explores their evolving role, trends in consolidation and the impact on branded drug access, growth of the 340B program and financial considerations, and more, and then maps out the key business questions for life science organizations to address when developing a health system strategy. (November 2021)